Autologous Stem Cell Transplantation for Multiple Myeloma: Underutilized but Highly Effective

Affiliations

Comment

John P Chute. J Natl Cancer Inst. 2019.

. 2019 Jan 1;111(1):7-8.

doi: 10.1093/jnci/djy102.

¹ Division of Hematology/Oncology, Department of Medicine, University of California at Los Angeles, CA.

No abstract available

Comment on

Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma.
Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T. Rosenberg AS, et al. J Natl Cancer Inst. 2019 Jan 1;111(1):78-85. doi: 10.1093/jnci/djy073. J Natl Cancer Inst. 2019. PMID: 29897481 Free PMC article.

Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.
Sauer S, Pavel P, Schmitt A, Cremer M, Kriegsmann M, Bruckner T, Jordan K, Wuchter P, Müller-Tidow C, Kriegsmann K. Sauer S, et al. BMC Cancer. 2020 Apr 25;20(1):353. doi: 10.1186/s12885-020-06873-7. BMC Cancer. 2020. PMID: 32334570 Free PMC article.
Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma.
Sauer S, Kriegsmann K, Nientiedt C, Schmitt A, Müller-Tidow C, Raab MS, Kauer J. Sauer S, et al. Transfus Med Hemother. 2023 Mar 24;50(5):371-381. doi: 10.1159/000529691. eCollection 2023 Oct. Transfus Med Hemother. 2023. PMID: 37936633 Free PMC article.
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma.
Merz M, Dechow T, Scheytt M, Schmidt C, Hackanson B, Knop S. Merz M, et al. Ann Hematol. 2020 Aug;99(8):1709-1725. doi: 10.1007/s00277-020-04023-4. Epub 2020 Apr 16. Ann Hematol. 2020. PMID: 32296915 Free PMC article. Review.